Hazel Hunt

Hazel Hunt

Chief Tech/Sci/R&D Officer at CORCEPT THERAPEUTICS INCORPORATED

Net worth: 29 M $ as of 30/09/2026

66 year
Consumer Services
Health Technology
Commercial Services

Profile

Hazel Hunt currently works at Corcept Therapeutics, Inc., as Chief Scientific Officer from 2020.
Dr. Hunt also formerly worked at Pulmagen Therapeutics (Synergy) Ltd., as Operations Director from 2002 to 2011, Argenta Bank en Verzekeringsgroep NV, as Director-Chemistry & Operations from 2002 to 2011, the University of Oxford, as Principal, the University of California, Davis, as Principal, and Glaxo Group Research Ltd., as Senior Chemist.
Dr. Hunt received her undergraduate degree from The Australian National University and doctorate degree from The University of Southampton.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
27/02/2026 255,437 ( 0.24% ) 29 M $ 30/09/2026

Hazel Hunt active positions

CompaniesPositionStart
CORCEPT THERAPEUTICS INCORPORATED Chief Tech/Sci/R&D Officer 01/01/2011

Former positions of Hazel Hunt

CompaniesPositionEnd
Chief Operating Officer 01/01/2011
Corporate Officer/Principal 01/01/2011
Glaxo Group Research Ltd.
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
See the detail of Hazel Hunt's experience

Education of Hazel Hunt

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

43

1st degree connections

8

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies8

Health Technology

Consumer Services

Consumer Services

Consumer Services

Commercial Services

Consumer Services

Finance

Glaxo Group Research Ltd.